2024-04-012025-03-312025-03-31false10556348MASSILLIA LIMITED2025-12-15falseiso4217:GBPxbrli:pure105563482024-03-31105563482025-03-31105563482024-04-012025-03-31105563482023-03-31105563482024-03-31105563482023-04-012024-03-3110556348bus:SmallEntities2024-04-012025-03-3110556348bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3110556348bus:FullAccounts2024-04-012025-03-3110556348bus:PrivateLimitedCompanyLtd2024-04-012025-03-3110556348core:WithinOneYear2025-03-3110556348core:AfterOneYear2025-03-3110556348core:WithinOneYear2024-03-3110556348core:AfterOneYear2024-03-3110556348core:ShareCapital2025-03-3110556348core:SharePremium2025-03-3110556348core:RevaluationReserve2025-03-3110556348core:OtherReservesSubtotal2025-03-3110556348core:RetainedEarningsAccumulatedLosses2025-03-3110556348core:ShareCapital2024-03-3110556348core:SharePremium2024-03-3110556348core:RevaluationReserve2024-03-3110556348core:OtherReservesSubtotal2024-03-3110556348core:RetainedEarningsAccumulatedLosses2024-03-3110556348core:LandBuildings2025-03-3110556348core:PlantMachinery2025-03-3110556348core:Vehicles2025-03-3110556348core:FurnitureFittings2025-03-3110556348core:OfficeEquipment2025-03-3110556348core:NetGoodwill2025-03-3110556348core:IntangibleAssetsOtherThanGoodwill2025-03-3110556348core:ListedExchangeTraded2025-03-3110556348core:UnlistedNon-exchangeTraded2025-03-3110556348core:LandBuildings2024-03-3110556348core:PlantMachinery2024-03-3110556348core:Vehicles2024-03-3110556348core:FurnitureFittings2024-03-3110556348core:OfficeEquipment2024-03-3110556348core:NetGoodwill2024-03-3110556348core:IntangibleAssetsOtherThanGoodwill2024-03-3110556348core:ListedExchangeTraded2024-03-3110556348core:UnlistedNon-exchangeTraded2024-03-3110556348core:LandBuildings2024-04-012025-03-3110556348core:PlantMachinery2024-04-012025-03-3110556348core:Vehicles2024-04-012025-03-3110556348core:FurnitureFittings2024-04-012025-03-3110556348core:OfficeEquipment2024-04-012025-03-3110556348core:NetGoodwill2024-04-012025-03-3110556348core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3110556348core:ListedExchangeTraded2024-04-012025-03-3110556348core:UnlistedNon-exchangeTraded2024-04-012025-03-3110556348core:MoreThanFiveYears2024-04-012025-03-3110556348core:Non-currentFinancialInstruments2025-03-3110556348core:Non-currentFinancialInstruments2024-03-3110556348dpl:CostSales2024-04-012025-03-3110556348dpl:DistributionCosts2024-04-012025-03-3110556348core:LandBuildings2024-04-012025-03-3110556348core:PlantMachinery2024-04-012025-03-3110556348core:Vehicles2024-04-012025-03-3110556348core:FurnitureFittings2024-04-012025-03-3110556348core:OfficeEquipment2024-04-012025-03-3110556348dpl:AdministrativeExpenses2024-04-012025-03-3110556348core:NetGoodwill2024-04-012025-03-3110556348core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3110556348dpl:GroupUndertakings2024-04-012025-03-3110556348dpl:ParticipatingInterests2024-04-012025-03-3110556348dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3110556348core:ListedExchangeTraded2024-04-012025-03-3110556348dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3110556348core:UnlistedNon-exchangeTraded2024-04-012025-03-3110556348dpl:CostSales2023-04-012024-03-3110556348dpl:DistributionCosts2023-04-012024-03-3110556348core:LandBuildings2023-04-012024-03-3110556348core:PlantMachinery2023-04-012024-03-3110556348core:Vehicles2023-04-012024-03-3110556348core:FurnitureFittings2023-04-012024-03-3110556348core:OfficeEquipment2023-04-012024-03-3110556348dpl:AdministrativeExpenses2023-04-012024-03-3110556348core:NetGoodwill2023-04-012024-03-3110556348core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3110556348dpl:GroupUndertakings2023-04-012024-03-3110556348dpl:ParticipatingInterests2023-04-012024-03-3110556348dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3110556348core:ListedExchangeTraded2023-04-012024-03-3110556348dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3110556348core:UnlistedNon-exchangeTraded2023-04-012024-03-3110556348core:NetGoodwill2025-03-3110556348core:IntangibleAssetsOtherThanGoodwill2025-03-3110556348core:LandBuildings2025-03-3110556348core:PlantMachinery2025-03-3110556348core:Vehicles2025-03-3110556348core:FurnitureFittings2025-03-3110556348core:OfficeEquipment2025-03-3110556348core:AfterOneYear2025-03-3110556348core:WithinOneYear2025-03-3110556348core:ListedExchangeTraded2025-03-3110556348core:UnlistedNon-exchangeTraded2025-03-3110556348core:ShareCapital2025-03-3110556348core:SharePremium2025-03-3110556348core:RevaluationReserve2025-03-3110556348core:OtherReservesSubtotal2025-03-3110556348core:RetainedEarningsAccumulatedLosses2025-03-3110556348core:NetGoodwill2024-03-3110556348core:IntangibleAssetsOtherThanGoodwill2024-03-3110556348core:LandBuildings2024-03-3110556348core:PlantMachinery2024-03-3110556348core:Vehicles2024-03-3110556348core:FurnitureFittings2024-03-3110556348core:OfficeEquipment2024-03-3110556348core:AfterOneYear2024-03-3110556348core:WithinOneYear2024-03-3110556348core:ListedExchangeTraded2024-03-3110556348core:UnlistedNon-exchangeTraded2024-03-3110556348core:ShareCapital2024-03-3110556348core:SharePremium2024-03-3110556348core:RevaluationReserve2024-03-3110556348core:OtherReservesSubtotal2024-03-3110556348core:RetainedEarningsAccumulatedLosses2024-03-3110556348core:NetGoodwill2023-03-3110556348core:IntangibleAssetsOtherThanGoodwill2023-03-3110556348core:LandBuildings2023-03-3110556348core:PlantMachinery2023-03-3110556348core:Vehicles2023-03-3110556348core:FurnitureFittings2023-03-3110556348core:OfficeEquipment2023-03-3110556348core:AfterOneYear2023-03-3110556348core:WithinOneYear2023-03-3110556348core:ListedExchangeTraded2023-03-3110556348core:UnlistedNon-exchangeTraded2023-03-3110556348core:ShareCapital2023-03-3110556348core:SharePremium2023-03-3110556348core:RevaluationReserve2023-03-3110556348core:OtherReservesSubtotal2023-03-3110556348core:RetainedEarningsAccumulatedLosses2023-03-3110556348core:AfterOneYear2024-04-012025-03-3110556348core:WithinOneYear2024-04-012025-03-3110556348core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3110556348core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3110556348core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3110556348core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3110556348core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3110556348core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3110556348core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3110556348core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3110556348core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3110556348core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3110556348core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3110556348core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3110556348core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3110556348core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3110556348core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3110556348core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3110556348core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3110556348core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3110556348core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3110556348core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3110556348core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3110556348core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3110556348core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3110556348core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3110556348core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3110556348core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3110556348core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3110556348bus:Director12024-04-012025-03-31

MASSILLIA LIMITED

Registered Number
10556348
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

MASSILLIA LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Director

Dr Essam Salem Shawkat

Registered Address

10 Lark Hill
Batley
WF17 0QR

Registered Number

10556348 (England and Wales)
MASSILLIA LIMITED
Statement of Financial Position
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets34,1332,099
4,1332,099
Current assets
Debtors485,3298,096
Cash at bank and on hand52,78179,484
138,11087,580
Creditors amounts falling due within one year5(41,305)(25,903)
Net current assets (liabilities)96,80561,677
Total assets less current liabilities100,93863,776
Creditors amounts falling due after one year6(5,100)(6,585)
Provisions for liabilities7(785)(399)
Net assets95,05356,792
Capital and reserves
Called up share capital200200
Profit and loss account94,85356,592
Shareholders' funds95,05356,792
The financial statements were approved and authorised for issue by the Director on 15 December 2025, and are signed on its behalf by:
Dr Essam Salem Shawkat
Director
Registered Company No. 10556348
MASSILLIA LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Basis of preparation
The financial statements have been prepared on the historical cost basis.
Functional and presentation currency
The financial statements are presented in sterling, which is the functional currency of the entity.
Going concern
The UK economy has recently been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.
Revenue from sale of goods
The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year end date is recognised by reference to the state of completion.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
Current taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amount of tax expected to pay or recover using the tax rates and laws that have been enacted, or substantively enacted, at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted, or substantively enacted, by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible fixed assets and depreciation
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Reducing balance (%)
Office Equipment25
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2.Average number of employees

20252024
Average number of employees during the year12
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 April 243,2003,200
Additions3,4103,410
At 31 March 256,6106,610
Depreciation and impairment
At 01 April 241,1011,101
Charge for year1,3761,376
At 31 March 252,4772,477
Net book value
At 31 March 254,1334,133
At 31 March 242,0992,099
4.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables13,1048,096
Other debtors72,225-
Total85,3298,096
5.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables-8,360
Bank borrowings and overdrafts1,0096,220
Taxation and social security39,06210,209
Accrued liabilities and deferred income1,2341,114
Total41,30525,903
6.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts5,1006,585
Total5,1006,585
7.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)785399
Total785399
8.Related party transactions
During the year the company loaned the Director £54,000 (2024: - £1,596). This amount is repayable upon demand. Interest has been accrued in line with the Bank of England base rate.